Cingulate (CING) Competitors $3.83 -0.02 (-0.52%) (As of 11/4/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends CING vs. TRIB, WVFC, HOOK, PRPH, IMMX, FBIO, VTVT, CLNN, RLYB, and DRRXShould you be buying Cingulate stock or one of its competitors? The main competitors of Cingulate include Trinity Biotech (TRIB), WVS Financial (WVFC), Hookipa Pharma (HOOK), ProPhase Labs (PRPH), Immix Biopharma (IMMX), Fortress Biotech (FBIO), vTv Therapeutics (VTVT), Clene (CLNN), Rallybio (RLYB), and DURECT (DRRX). Cingulate vs. Trinity Biotech WVS Financial Hookipa Pharma ProPhase Labs Immix Biopharma Fortress Biotech vTv Therapeutics Clene Rallybio DURECT Trinity Biotech (NASDAQ:TRIB) and Cingulate (NASDAQ:CING) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, risk, community ranking, valuation, profitability, earnings, institutional ownership, dividends and media sentiment. Which has more risk & volatility, TRIB or CING? Trinity Biotech has a beta of 1.13, indicating that its stock price is 13% more volatile than the S&P 500. Comparatively, Cingulate has a beta of -0.89, indicating that its stock price is 189% less volatile than the S&P 500. Which has better valuation & earnings, TRIB or CING? Cingulate has lower revenue, but higher earnings than Trinity Biotech. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTrinity Biotech$58.65M0.22-$24.02M-$2.70-0.63CingulateN/AN/A-$23.53MN/AN/A Is TRIB or CING more profitable? Cingulate has a net margin of 0.00% compared to Trinity Biotech's net margin of -38.02%. Company Net Margins Return on Equity Return on Assets Trinity Biotech-38.02% N/A -26.62% Cingulate N/A N/A -382.24% Do analysts rate TRIB or CING? Cingulate has a consensus target price of $8.00, suggesting a potential upside of 108.88%. Given Cingulate's higher probable upside, analysts plainly believe Cingulate is more favorable than Trinity Biotech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Trinity Biotech 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/ACingulate 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33 Does the MarketBeat Community favor TRIB or CING? Trinity Biotech received 329 more outperform votes than Cingulate when rated by MarketBeat users. Likewise, 72.04% of users gave Trinity Biotech an outperform vote while only 66.67% of users gave Cingulate an outperform vote. CompanyUnderperformOutperformTrinity BiotechOutperform Votes33572.04% Underperform Votes13027.96% CingulateOutperform Votes666.67% Underperform Votes333.33% Do institutionals & insiders have more ownership in TRIB or CING? 79.0% of Trinity Biotech shares are owned by institutional investors. Comparatively, 41.3% of Cingulate shares are owned by institutional investors. 8.2% of Trinity Biotech shares are owned by company insiders. Comparatively, 17.1% of Cingulate shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Does the media refer more to TRIB or CING? In the previous week, Cingulate had 3 more articles in the media than Trinity Biotech. MarketBeat recorded 3 mentions for Cingulate and 0 mentions for Trinity Biotech. Trinity Biotech's average media sentiment score of 0.00 beat Cingulate's score of -0.38 indicating that Trinity Biotech is being referred to more favorably in the media. Company Overall Sentiment Trinity Biotech Neutral Cingulate Neutral SummaryTrinity Biotech beats Cingulate on 7 of the 13 factors compared between the two stocks. Ad Crypto 101 MediaBlackrock’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW Get Cingulate News Delivered to You Automatically Sign up to receive the latest news and ratings for CING and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CING vs. The Competition Export to ExcelMetricCingulatePharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$11.66M$6.79B$5.11B$8.43BDividend YieldN/A7.94%7.46%4.16%P/E RatioN/A12.45131.2116.71Price / SalesN/A271.041,649.6876.32Price / CashN/A46.0937.4533.56Price / Book-0.055.284.624.98Net Income-$23.53M$152.08M$116.18M$224.69M7 Day Performance-12.76%-1.46%-0.69%-0.51%1 Month Performance-20.37%14.88%5.66%3.32%1 Year Performance-54.13%37.01%34.02%25.51% Cingulate Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CINGCingulate2.4406 of 5 stars$3.83-0.5%$8.00+108.9%-54.1%$11.66MN/A0.0013Upcoming EarningsTRIBTrinity Biotech0.4635 of 5 stars$1.69-4.0%N/A-26.4%$12.88M$56.83M-0.63480Gap DownWVFCWVS FinancialN/A$12.32flatN/A+0.6%$23.29M$16.11M13.2520Dividend AnnouncementPositive NewsHOOKHookipa Pharma3.3196 of 5 stars$3.84+1.3%$44.67+1,063.2%-18.4%$46.29M$52.16M-0.8956Gap UpPRPHProPhase Labs3.0408 of 5 stars$2.14-6.6%$11.00+414.0%-51.8%$43.69M$44.38M-1.77130IMMXImmix Biopharma3.1455 of 5 stars$1.59-0.6%$7.00+340.3%-55.7%$43.65MN/A-1.899Gap UpFBIOFortress Biotech2.8359 of 5 stars$1.90flat$13.00+584.2%-22.8%$43.34M$84.51M-0.59186Upcoming EarningsNews CoverageGap UpHigh Trading VolumeVTVTvTv TherapeuticsN/A$14.03+2.3%N/A-10.3%$42.23M$2.02M-2.059Gap DownCLNNClene3.5702 of 5 stars$6.11-3.8%$72.33+1,083.9%-29.8%$41.92M$650,000.00-1.37100RLYBRallybio3.103 of 5 stars$1.01-1.9%$10.00+890.1%-75.4%$41.91MN/A-0.5640DRRXDURECT2.7255 of 5 stars$1.34+1.5%$21.00+1,467.2%-50.5%$41.59M$8.55M-2.2080Upcoming EarningsAnalyst Forecast Related Companies and Tools Related Companies Trinity Biotech Competitors WVS Financial Competitors Hookipa Pharma Competitors ProPhase Labs Competitors Immix Biopharma Competitors Fortress Biotech Competitors vTv Therapeutics Competitors Clene Competitors Rallybio Competitors DURECT Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CING) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredMissed Out On Nvidia?Artificial Intelligence is a tool with the potential to create massive distributions of wealth… In fact, it...Unstoppable Prosperity | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredCrypto Crash Ahead? (27 Experts Weigh In)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Crypto 101 Media | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cingulate Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cingulate With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CING Stock Alerts